Sy Egco, Jose .

HRN: 28-77-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/06/2026
05/13/2026
IV
1100mg
Q24
PTB Bacteriologically Confirmed
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines